Buspirone Hydrochloride Tablet
Product Images NDC 70518-0380

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 70518-0380). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

3e7fdbd9 38d4 4315 A4b1 F2967fd6ed7b 01

FDA Label Image

3e7fdbd9 38d4 4315 A4b1 F2967fd6ed7b 02

This text provides information on how to divide tablets of 15 mg and 30 mg into smaller doses as prescribed by a doctor. It gives the fractions of the tablets to be taken to obtain doses of 5, 7.5, 10 and 20 mg for the 15 mg tablet, and 10 and 15 mg for the 30 mg tablet.*

FDA Label Image

3e7fdbd9 38d4 4315 A4b1 F2967fd6ed7b 03

FDA Label Image

Remedy_label (Remedy Label)

busPIRone HCI is medication in tablet form, with a strength of 15mg. The package contains 30 tablets for personal use only as indicated by the "RXONLY" label. The product is manufactured by Zydus Pharm in Pennington, NJ and the National Drug Code is 70518-0380-00. The storage instructions recommend keeping the medication at 20-25°C (68-77°F), with brief temperature excursions permitted to 15-30°C (59-86°F). The packaging includes instruction to check the package insert for directions on use and the manufacturer is RemedyRepack, Indiana, PA 15701, with a contact number of 724.465.8762.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.